Valeda® Light Delivery System by LumiThera Collection (10 videos)

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Symposia Introduction: Treatment for Dry Age-Related Macular Degeneration Using Photobiomodulation

Channels: Retina

Leading photobiomodulation (PBM) experts Clark Tedford, PhD; Janis T. Eells, PhD; and Marion R. Munk, MD, PhD, discuss the PBM mechanism of action and review clinical data supporting the efficacy and safety of PBM and the impact on anatomical and functional endpoints.

dry age-related macular degeneration, dry AMD • photobiomodulation • Valeda

Visit Us Online

© 2020 LumiThera, Inc. www.lumithera.com

MKT-0039 REV A

Valeda is CE Marked in the EU.

Valeda is in clinical trials and not approved for use in the United States